Many studies have shown the inhibitory effect of polyphenolic compounds including green tea catechins (-)epigallocatechin 3-gallate (EGCG) against carcinogenesis in rodent models. These include cancers of the colorectal, liver, lung, skin, small intestine, and mammary gland. Our hypothesis is that the cancer chemoprevention effect of tea polyphenolic components such as EGCG, is through induction of apoptotic mechanisms involving the mitogen-activated protein kinases (MAPK) pathway, and the caspases pathway. The overall goal of this project is to identify the molecular mechanisms/targets of apoptotic signaling molecules exhibited by EGCG and other tea polyphenols. Such knowledge will help to develop better chemopreventive agents and to design more effective cancer chemoprevention clinical trials. To test this hypothesis, we will use different cell culture models with the following specific aims: (1) To investigate whether the activation of the MAPK (ERK, JNK, and p38) pathway by EGCG and other tea polyphenols in two human tumor cell line models (cervical squamous carcinoma HeLa, and colon HT29) is involved in apoptosis. Transfection studies with various cDNA constructs encoding for the MAPK cascade as well as structure-activity relationship of the tea polyphenols in MAPK-induced apoptosis will be performed. (2) To determine whether the stimulation of the caspase (the mitochondria-cytochrome c release pathway and the nonmitochondria-cytochrome c release pathway) pathway induced by EGCG and other tea polyphenols in the two human tumor cell lines (HeLa and HT29) is involved in apoptosis. Transfection studies with cDNAs encoding the anti-apoptotic proteins (Bc12 and CrmA) and pro-apoptotic proteins (death receptors -Fas, TNFR, DR4/5, and Bax, Bid) as well as structure-activity relationship of the tea polyphenols in caspase-induced apoptosis will be performed. These studies will complement the studies in Aim 1 and will provide further understanding of the apoptotic signaling mechanisms of tea polyphenolic compounds. Our long-term goal is to identify the molecular targets of the chemopreventive effect exhibited by EGCG and other tea polyphenols. Such knowledge will help to develop better chemopreventive compounds and to design more effective cancer chemoprevention clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA092515-03S1
Application #
6879303
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Rosenfeld, Bobby
Project Start
2002-04-01
Project End
2007-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
3
Fiscal Year
2004
Total Cost
$11,079
Indirect Cost
Name
Rutgers University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
001912864
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Gopalakrishnan, Avanthika; Tony Kong, Ah-Ng (2008) Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells. Food Chem Toxicol 46:1257-70
Shen, Guoxiang; Khor, Tin Oo; Hu, Rong et al. (2007) Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res 67:9937-44
Kwon, Ki Han; Barve, Avantika; Yu, Siwang et al. (2007) Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol Sin 28:1409-21
Nair, Sujit; Li, Wenge; Kong, Ah-Ng Tony (2007) Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells. Acta Pharmacol Sin 28:459-72
Khor, Tin Oo; Ibrahim, Sherif; Kong, Ah-Ng Tony (2006) Toxicogenomics in drug discovery and drug development: potential applications and future challenges. Pharm Res 23:1659-64
Kim, Jung-Hwan; Xu, Changjiang; Keum, Young-Sam et al. (2006) Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27:475-82
Shen, Guoxiang; Xu, Changjiang; Hu, Rong et al. (2005) Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Pharm Res 22:1805-20
Shen, Guoxiang; Jeong, Woo-Sik; Hu, Rong et al. (2005) Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents. Antioxid Redox Signal 7:1648-63
Chen, Chi; Kong, Ah-Ng Tony (2005) Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. Trends Pharmacol Sci 26:318-26
Jeong, Woo-Sik; Kim, In-Wha; Hu, Rong et al. (2004) Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm Res 21:661-70

Showing the most recent 10 out of 13 publications